In the News: First-Ever AI Parameters Ruling; New Pharma Strategy; and Market Access Restrictions Eased

Beijing IP Court issues first ruling on protecting AI model parameters; Chinese pharma companies are using “NewCo” strategy to expand overseas; and China reduces entry restrictions for select industries.

Credit: Timon/Adobe Stock


Douyin Wins AI Model Unfair Competition Case


On March 31, 2025, the Beijing Intellectual Property Court issued a landmark judgment which, for the first time in China, held that the structure and parameters of AI models “constitute competitive interests protected under the Anti-Unfair Competition Law.”

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]